| Application no. and date | 00954625.0 (espacenet) (Federated) (European Patent Register), 20000811 | | Patent/reg. no. and date | DK/EP 1212089, 20060322 | | Publication date | 20020612 | | Priority no. and date | EP 99116447, 19990821 | | EP pub. no. and date |
EP 1212089 20020612 | | Effective date | | | Applicant/owner | AstraZeneca AB,
SE 151 85 Södertälje, SE | | Applicant ref. no. | 40792 DK 01 | | Inventor | BEUME, Rolf, Bohlstrasse 13
D-78465 Konstanz, DE,
KILIAN, Ulrich, Am Dachsberg 18
D-78479 Reichenau, DE,
HATZELMANN, Armin, Alter Wall 3
D-78467 Konstanz, DE,
SCHUDT, Christian, Schützenstrasse 20
D-78462 Konstanz, DE,
BUNDSCHUH, Daniela, im rank 5
CH-8272 Ermatingen, CH,
WEIMAR, Christian, Helene und Maria Schiess-str. 29
D-78467 Konstanz, DE | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/138 (2006.01) , A61K 31/44 (2006.01) , A61P 11/00 (2006.01) | | Title | Synergistisk kombination af Roflumilast og Salmeterol | | Int. application no. | EP2000007852 | | Int. publication no. | WO2001013953 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
